Seventy-four adults aged 25 to 60 with overweight or obesity were randomized to one of three diets: a low-dairy, calorie-restricted plan; an energy-neutral plan with three daily servings of full-fat dairy; or an unrestricted plan with three daily servings. After 12 weeks, there were no meaningful differences in weight gain, body composition, or cholesterol between the low-dairy group and the dairy groups, and the dairy groups showed improvements in blood pressure with higher calcium, protein, and vitamin D intake.
Three limits belong in any honest reading. The trial was small — about two dozen per arm. It measured surrogate markers (weight, cholesterol), not heart attacks or strokes. And it was funded through the Dairy Research Cluster 3 under the Canadian Agricultural Partnership, an industry-linked program — the pattern in nutrition research where industry-funded studies tend to favor the sponsor operates at the level of the literature, not this paper, but the funding belongs in the conversation. The narrow takeaway is that within a 12-week structured diet, three daily servings of full-fat dairy did not worsen the markers measured. It is not proof that full-fat dairy improves health, and it is not a reason to change what a clinician has prescribed.
For stone patients, the trial's fat-content finding is secondary to its calcium finding — and the calcium finding is the stone diet's oldest rule. Dietary calcium at meals binds oxalate in the gut and is associated with lower stone risk, and the dairy matrix — the physical structure in which casein, whey, fat, and minerals are packaged — is how the calcium arrives. Whether the dairy is full-fat or low-fat does not change its oxalate column: milk, yogurt, and cheese all measure zero oxalate regardless of fat content. The stone patient choosing between whole milk and skim is choosing between two zero-oxalate options; the decision that matters is whether the dairy is at the meal.
The table below shows the measured oxalate values of the dairy options — the column that matters for stones, which does not change with fat content.
| Food | Oxalate (mg) | Serving | Rating |
|---|---|---|---|
| Milk, whole | 0 | 1 cup | Safe |
| Milk, 2% reduced-fat | 0 | 1 cup | Safe |
| Milk, skim | 0 | 1 cup | Safe |
| Greek yogurt, plain | 0 | 1 cup | Safe |
| Cheddar cheese | 0 | 1 oz | Safe |
| Cottage cheese | 0 | 1/2 cup | Safe |
| Ice cream, vanilla | 0 | 1/2 cup | Safe |
| Chocolate (paired with milk) | 61 | 1 oz | Caution |
The trial's practical message for stone patients is permissive: the dairy shelf does not need to be a low-fat shelf. The stone plan's calcium target — three servings a day at meals — is the same target the trial fed its participants, and the choice between full-fat and low-fat can be made on taste and overall calories rather than stone risk. The calcium at meals, the water on schedule, and the measured portions remain the levers; the fat content of the milk was never one of them. The person who has been avoiding dairy or choosing only fat-free versions out of habit can set the habit aside — the dairy is the stone diet's most protective food group, in any fat content.
Yes — the fat content does not change the oxalate column: milk, yogurt, and cheese measure zero oxalate in every fat level. The stone-relevant value of dairy is the calcium at meals, which binds oxalate. The full-fat versus low-fat choice is about calories and taste, not stone risk.
No — it is a small, dairy-industry-funded trial measuring surrogate markers over 12 weeks. It shows three daily servings did not worsen the markers measured. The durable message is the calcium, which the stone diet has relied on all along.
The stone diet's target is about three servings a day at meals — milk, yogurt, cheese — which delivers the calcium that binds oxalate. The trial fed exactly that amount. The dairy at the meal is the point; the fat content is not.
The dairy aisle is the practical meeting point of the trial and the stone plan: whole milk, 2%, skim, and the yogurt and cheese shelves all carry the same zero-oxalate column, and the choice between them is about calories and taste, not stone risk. The measured version of the aisle is the same as the trial's plate — about three servings a day, at meals, in whatever fat content fits the household's overall calorie pattern. The person who has been avoiding dairy because of a lingering low-fat habit — or skipping it entirely because "dairy is fattening" — can set that habit aside, because the stone plan's most protective food group was never the fat column. The aisle decision is a calorie decision; the stone decision is whether the dairy is at the meal.
The trial's funding note belongs in the practical reading too: the result is a data point, not a verdict, and people managing high cholesterol or cardiovascular disease should follow their clinician's guidance rather than a single 74-person trial. The stone-relevant message — calcium at meals, in any fat level — does not depend on the trial; it is the stone diet's oldest rule, and the trial simply adds one more piece of evidence that the dairy shelf is safe to use.
See how oxalate values are measured and verified on our data methodology page.